A Comprehensive Approach to Treatment-Resistant Depression: Addressing Gender Disparities, Psychotherapy Integration, and Emerging Avenues

Treatment-resistant depression (TRD) poses a significant challenge, affecting up to 60% of patients who do not respond to standard antidepressant treatments (Fava, 2003). Gender disparities in TRD are evident, with women experiencing higher prevalence rates and greater responsiveness to treatments compared to men (Patel et al., 2024; Angst et al., 2002). The inconsistent definition of TRD complicates treatment approaches, highlighting the importance of incorporating psychotherapy into treatment plans and achieving a consensus on TRD criteria (Markowitz et al., 2022; Gaynes et al., 2020). Psychotherapies, such as Cognitive Behavioural Therapy (CBT) and Mindfulness-Based Cognitive Therapy (MBCT), have shown efficacy in TRD, challenging the traditional focus on pharmacological interventions alone (Markowitz et al., 2022; Eisendrath et al., 2011). Emerging research on the gut-brain axis and the role of psychobiotics offers a promising new avenue for TRD treatment, with potential benefits in neurotransmitter regulation and inflammation reduction (Skowron et al., 2022; Palepu & Dandekar, 2022). A holistic, personalised approach integrating these diverse strategies is essential to improving TRD outcomes and patient quality of life.